TY - JOUR
T1 - Decreased production of epithelial-derived antimicrobial molecules at mucosal barriers during early life
AU - Lokken-Toyli, Kristen L.
AU - de Steenhuijsen Piters, Wouter A.A.
AU - Zangari, Tonia
AU - Martel, Rachel
AU - Kuipers, Kirsten
AU - Shopsin, Bo
AU - Loomis, Cynthia
AU - Bogaert, Debby
AU - Weiser, Jeffrey N.
N1 - Funding Information:
This work was supported by grants R01 AI150893 and R01 AI038446. K.L.L.T. was supported by NIH grants F32 AI143043 and T32 A1007180-35. R01 AI137336-01A1 and 1R01 AI140754-01A1 supported B.S. We would like to thank the Applied Bioinformatics Center, Genome Technology Center and Experimental Pathology Research Laboratory at NYU. The core centers are partially supported by the Cancer Center Support Grant P30CA016087.
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Society for Mucosal Immunology.
PY - 2021/11
Y1 - 2021/11
N2 - Young age is a risk factor for respiratory and gastrointestinal infections. Here, we compared infant and adult mice to identify age-dependent mechanisms that drive susceptibility to mucosal infections during early life. Transcriptional profiling of the upper respiratory tract (URT) epithelium revealed significant dampening of early life innate mucosal defenses. Epithelial-mediated production of the most abundant antimicrobial molecules, lysozyme, and lactoferrin, and the polymeric immunoglobulin receptor (pIgR), responsible for IgA transcytosis, was expressed in an age-dependent manner. This was attributed to delayed functional development of serous cells. Absence of epithelial-derived lysozyme and the pIgR was also observed in the small intestine during early life. Infection of infant mice with lysozyme-susceptible strains of Streptococcus pneumoniae or Staphylococcus aureus in the URT or gastrointestinal tract, respectively, demonstrated an age-dependent regulation of lysozyme enzymatic activity. Lysozyme derived from maternal milk partially compensated for the reduction in URT lysozyme activity of infant mice. Similar to our observations in mice, expression of lysozyme and the pIgR in nasopharyngeal samples collected from healthy human infants during the first year of life followed an age-dependent regulation. Thus, a global pattern of reduced antimicrobial and IgA-mediated defenses may contribute to increased susceptibility of young children to mucosal infections.
AB - Young age is a risk factor for respiratory and gastrointestinal infections. Here, we compared infant and adult mice to identify age-dependent mechanisms that drive susceptibility to mucosal infections during early life. Transcriptional profiling of the upper respiratory tract (URT) epithelium revealed significant dampening of early life innate mucosal defenses. Epithelial-mediated production of the most abundant antimicrobial molecules, lysozyme, and lactoferrin, and the polymeric immunoglobulin receptor (pIgR), responsible for IgA transcytosis, was expressed in an age-dependent manner. This was attributed to delayed functional development of serous cells. Absence of epithelial-derived lysozyme and the pIgR was also observed in the small intestine during early life. Infection of infant mice with lysozyme-susceptible strains of Streptococcus pneumoniae or Staphylococcus aureus in the URT or gastrointestinal tract, respectively, demonstrated an age-dependent regulation of lysozyme enzymatic activity. Lysozyme derived from maternal milk partially compensated for the reduction in URT lysozyme activity of infant mice. Similar to our observations in mice, expression of lysozyme and the pIgR in nasopharyngeal samples collected from healthy human infants during the first year of life followed an age-dependent regulation. Thus, a global pattern of reduced antimicrobial and IgA-mediated defenses may contribute to increased susceptibility of young children to mucosal infections.
UR - http://www.scopus.com/inward/record.url?scp=85114619674&partnerID=8YFLogxK
U2 - 10.1038/s41385-021-00438-y
DO - 10.1038/s41385-021-00438-y
M3 - Article
C2 - 34465896
AN - SCOPUS:85114619674
SN - 1933-0219
VL - 14
SP - 1358
EP - 1368
JO - Mucosal immunology
JF - Mucosal immunology
IS - 6
ER -